Skip to main content

Table 1 Patient characteristics and demographics

From: The effect of the Xpert MTB/RIF test on the time to MDR-TB treatment initiation in a rural setting: a cohort study in South Africa’s Eastern Cape Province

Sex

n (%; 95% Confidence interval)

p-value

 Male

161 (56.5; 50.7–62.2)

 

 Female

124 (43.5; 37.8–49.3)

0.0019

 Total

285

 

AGE (Years) [category]

n (%; 95% Confidence interval)

 

  ≤ 18 [a]

14 (4.9; 2.4–7.4)

a vs b: <0.00001

 19–34 [b]

112 (39.3; 33.6–45.0)

a vs c: <0.00001

 35–49 [c]

100 (35.1; 29.5–40.6)

a vs d: <0.00001

  ≥ 50 [d]

59 (20.7; 16.0–25.4)

b vs c: 0.298

b vs d: <0.00001

c vs d: 0.0001

Age (Years) by Sex

Interquartile Range

Median

 

 Male

29–46

37

 

 Female

26–48.5

34

0.1513

 Total

27–48

36

 

HIV

n (%; 95% Confidence interval)

 

 Positive

175 (61.4; 55.8–67.1)

<0.0001

 Negative

110 (38.6; 32.9–44.2)

 

 ARV Patients

175 (61.4; 55.8–67.1)

<0.0001